1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Lymphedema Diagnostics Market, by Technology
6.1. Introduction
6.2. Bioimpedance Analysis
6.3. Computed Tomography
6.4. Lymphoscintigraphy
6.5. Magnetic Resonance Imaging
6.6. Near-Infrared Fluorescence Imaging
6.7. Ultrasound Imaging
6.8. X-Ray Lymphography

7. Lymphedema Diagnostics Market, by Disease
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disease
7.4. Inflammatory Diseases

8. Lymphedema Diagnostics Market, by End User
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research & Academic Institutes

9. California Lymphedema Diagnostics Market

10. Florida Lymphedema Diagnostics Market

11. Illinois Lymphedema Diagnostics Market

12. New York Lymphedema Diagnostics Market

13. Ohio Lymphedema Diagnostics Market

14. Pennsylvania Lymphedema Diagnostics Market

15. Texas Lymphedema Diagnostics Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Canon, Inc.
17.2. Curadel, LLC
17.3. Esaote SPA
17.4. Fluoptics
17.5. GE Healthcare
17.6. Hitachi, Ltd.
17.7. Koninklijke Philips N.V.
17.8. Neusoft Corporation
17.9. Other Companies
17.10. Shimadzu Corporation
17.11. Siemens Healthineers AG
17.12. Stryker Corporation
17.13. United Imaging Healthcare Co., Ltd.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 7. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY BIOIMPEDANCE ANALYSIS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY BIOIMPEDANCE ANALYSIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY LYMPHOSCINTIGRAPHY, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY LYMPHOSCINTIGRAPHY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY NEAR-INFRARED FLUORESCENCE IMAGING, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY NEAR-INFRARED FLUORESCENCE IMAGING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY X-RAY LYMPHOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY X-RAY LYMPHOGRAPHY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2020 VS 2026 (%)
FIGURE 22. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2020 VS 2026 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2026
FIGURE 24. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CANCER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 31. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2026
FIGURE 33. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 40. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 41. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY BIOIMPEDANCE ANALYSIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY LYMPHOSCINTIGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY NEAR-INFRARED FLUORESCENCE IMAGING, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY X-RAY LYMPHOGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: SCORES
TABLE 21. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: RANKING
TABLE 24. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 25. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 26. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 27. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 28. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 29. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 30. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

Canon, Inc.
Curadel, LLC
Esaote SPA
Fluoptics
GE Healthcare
Hitachi, Ltd.
Koninklijke Philips N.V.
Neusoft Corporation
Other Companies
Shimadzu Corporation
Siemens Healthineers AG
Stryker Corporation
United Imaging Healthcare Co., Ltd.